These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 24713399)

  • 1. Brain-derived neurotrophic factor blood levels are decreased in schizophrenia patients and associate with rs6265 genotypes.
    Zakharyan R; Boyajyan A
    Clin Biochem; 2014 Aug; 47(12):1052-5. PubMed ID: 24713399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of circulating BDNF levels with BDNF rs6265 polymorphism in schizophrenia.
    Kumar PK; Mitra P; Ghosh R; Sharma S; Nebhinani N; Sharma P
    Behav Brain Res; 2020 Sep; 394():112832. PubMed ID: 32726665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.
    Tan YL; Zhou DF; Cao LY; Zou YZ; Zhang XY
    Neurosci Lett; 2005 Jul 1-8; 382(1-2):27-32. PubMed ID: 15911116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review.
    Martinotti G; Di Iorio G; Marini S; Ricci V; De Berardis D; Di Giannantonio M
    J Biol Regul Homeost Agents; 2012; 26(3):347-56. PubMed ID: 23034254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine.
    Yamamori H; Hashimoto R; Ishima T; Kishi F; Yasuda Y; Ohi K; Fujimoto M; Umeda-Yano S; Ito A; Hashimoto K; Takeda M
    Neurosci Lett; 2013 Nov; 556():37-41. PubMed ID: 24141084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder.
    Gama CS; Andreazza AC; Kunz M; Berk M; Belmonte-de-Abreu PS; Kapczinski F
    Neurosci Lett; 2007 Jun; 420(1):45-8. PubMed ID: 17442489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BDNF Val66Met homozygosity does not influence plasma BDNF levels in healthy human subjects.
    Luykx JJ; Boks MP; Breetvelt EJ; Aukes MF; Strengman E; da Pozzo E; Dell'osso L; Marazziti D; van Leeuwen A; Vreeker A; Abramovic L; Martini C; Numans ME; Kahn RS; Ophoff RA
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():185-7. PubMed ID: 23269345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between brain-derived neurotrophic factor G196A gene polymorphism and clinical phenotypes in schizophrenia patients.
    Huang TL; Lee CT
    Chang Gung Med J; 2007; 30(5):408-13. PubMed ID: 18062171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
    Xiu MH; Hui L; Dang YF; Hou TD; Zhang CX; Zheng YL; Chen DC; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1508-12. PubMed ID: 19720106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.
    Pirildar S; Gönül AS; Taneli F; Akdeniz F
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia.
    Zhang XY; Zhou DF; Wu GY; Cao LY; Tan YL; Haile CN; Li J; Lu L; Kosten TA; Kosten TR
    Neuropsychopharmacology; 2008 Aug; 33(9):2200-5. PubMed ID: 17987059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia.
    Koolschijn PC; van Haren NE; Bakker SC; Hoogendoorn ML; Hulshoff Pol HE; Kahn RS
    Hippocampus; 2010 Sep; 20(9):1010-7. PubMed ID: 19714565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association study of brain-derived neurotrophic factor Val66Met polymorphism and clinical characteristics of first episode schizophrenia].
    Sun MM; Liu LF; Yang LM; Wang Y; Cui KY; Wang LN; Li CL; Qiao DD; Wang RZ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):155-8. PubMed ID: 22487823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes.
    Chen DC; Wang J; Wang B; Yang SC; Zhang CX; Zheng YL; Li YL; Wang N; Yang KB; Xiu MH; Kosten TR; Zhang XY
    Psychopharmacology (Berl); 2009 Dec; 207(3):375-80. PubMed ID: 19787338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BDNF serum concentrations in first psychotic episode drug-naïve schizophrenic patients: associations with personality and BDNF Val66Met polymorphism.
    Sotiropoulou M; Mantas C; Bozidis P; Marselos M; Mavreas V; Hyphantis T; Antoniou K
    Life Sci; 2013 Mar; 92(4-5):305-10. PubMed ID: 23333821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia.
    Rizos EN; Michalopoulou PG; Siafakas N; Stefanis N; Douzenis A; Rontos I; Laskos E; Kastania A; Zoumpourlis V; Lykouras L
    Neuropsychobiology; 2010; 62(2):87-90. PubMed ID: 20523079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation.
    Pedrini M; Chendo I; Grande I; Lobato MI; Belmonte-de-Abreu PS; Lersch C; Walz J; Kauer-Sant'anna M; Kapczinski F; Gama CS
    Neurosci Lett; 2011 Mar; 491(3):207-10. PubMed ID: 21256922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Val66Met functional polymorphism and serum protein level of brain-derived neurotrophic factor (BDNF) in acute episode of schizophrenia and depression.
    Skibinska M; Groszewska A; Kapelski P; Rajewska-Rager A; Pawlak J; Dmitrzak-Weglarz M; Szczepankiewicz A; Twarowska-Hauser J
    Pharmacol Rep; 2018 Feb; 70(1):55-59. PubMed ID: 29331787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional variants of the genes involved in neurodevelopment and susceptibility to schizophrenia in an Armenian population.
    Zakharyan R; Boyajyan A; Arakelyan A; Gevorgyan A; Mrazek F; Petrek M
    Hum Immunol; 2011 Sep; 72(9):746-8. PubMed ID: 21641949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interplay between BDNF and oxidative stress in chronic schizophrenia.
    Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Okusaga OO; Zunta-Soares GB; Soares JC
    Psychoneuroendocrinology; 2015 Jan; 51():201-8. PubMed ID: 25462893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.